Glia in tissue engineering: From biomaterial tools to transplantation

Area of Science:

• Neuroscience
• Biomaterials Science
• Regenerative Medicine

Background:

• Glia are crucial for nervous system functions, including repair and myelination, and hold therapeutic potential for central nervous system (CNS) disorders.
• Glial cells can act as double-edged swords in neuroinflammation, impacting neuronal survival.
• While glial grafting has shown promise, particularly for remyelination, few therapies have succeeded in clinical trials.

Purpose of the Study:

• To explore the therapeutic potential of glia in transplantation for CNS disorders.
• To emphasize novel bioengineered tools for enhancing the reparative properties of glial cells.
• To review biomaterial tools for glial transplantation, including Schwann cells, astrocytes, and others.

Main Methods:

• Review of existing literature on glial cell transplantation and bioengineered tools.
• Analysis of various glial cell types (Schwann cells, astrocytes, oligodendrocytes, microglia, ependymal cells) and their roles.
• Exploration of biomaterials such as scaffolds, peptides, and delivery systems for glial cell enhancement.

Main Results:

• Glia possess significant reparative potential for CNS disorders, with ongoing development of advanced bioengineered tools.
• Biomaterials and strategies like extracellular matrix scaffolds, bioactive peptides, and artificial channels are being developed to improve glial grafting success.
• Advances in stem cell technology enable patient-derived glial cell generation for transplantation.

Conclusions:

• Glia represent a promising cell type for treating CNS disorders through transplantation.
• Novel bioengineered tools and biomaterials are critical for enhancing glial cell reparative functions and overcoming clinical trial limitations.
• Further research into bioengineered tools for glial cell manipulation is needed to fully realize their therapeutic potential.